Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 37 entries
Sorted by: Best Match Show Resources per page
Ungewöhnliche Ulzerationen bei einem Patienten mit Diabetes mellitus.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Maier J, Kofler L, Beck V, Schweinzer K, Metzler G, Ghoreschi K.
PMID: 29750458
J Dtsch Dermatol Ges. 2018 May;16(5):623-626. doi: 10.1111/ddg.13501_g.

No abstract available.

Cite
Maier J, Kofler L, Beck V, et al. Ungewöhnliche Ulzerationen bei einem Patienten mit Diabetes mellitus. J Dtsch Dermatol Ges. 2018;16(5):623-626doi: 10.1111/ddg.13501_g.
Maier, J., Kofler, L., Beck, V., Schweinzer, K., Metzler, G., & Ghoreschi, K. (2018). Ungewöhnliche Ulzerationen bei einem Patienten mit Diabetes mellitus. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 16(5), 623-626. https://doi.org/10.1111/ddg.13501_g
Maier, Jens, et al. "Ungewöhnliche Ulzerationen bei einem Patienten mit Diabetes mellitus." Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG vol. 16,5 (2018): 623-626. doi: https://doi.org/10.1111/ddg.13501_g
Maier J, Kofler L, Beck V, Schweinzer K, Metzler G, Ghoreschi K. Ungewöhnliche Ulzerationen bei einem Patienten mit Diabetes mellitus. J Dtsch Dermatol Ges. 2018 May;16(5):623-626. doi: 10.1111/ddg.13501_g. PMID: 29750458.
Copy Download .nbib Format: NLM
Long-term follow-up of early-onset Sneddon syndrome: A case report.

JAAD case reports

Forchhammer S, Metzler G, Ghoreschi K.
PMID: 30306117
JAAD Case Rep. 2018 Oct 03;4(9):880-882. doi: 10.1016/j.jdcr.2018.08.008. eCollection 2018 Oct.

No abstract available.

Cite
Forchhammer S, Metzler G, Ghoreschi K. Long-term follow-up of early-onset Sneddon syndrome: A case report. JAAD Case Rep. 2018;4(9):880-882doi: 10.1016/j.jdcr.2018.08.008.
Forchhammer, S., Metzler, G., & Ghoreschi, K. (2018). Long-term follow-up of early-onset Sneddon syndrome: A case report. JAAD case reports, 4(9), 880-882. https://doi.org/10.1016/j.jdcr.2018.08.008
Forchhammer, Stephan, et al. "Long-term follow-up of early-onset Sneddon syndrome: A case report." JAAD case reports vol. 4,9 (2018): 880-882. doi: https://doi.org/10.1016/j.jdcr.2018.08.008
Forchhammer S, Metzler G, Ghoreschi K. Long-term follow-up of early-onset Sneddon syndrome: A case report. JAAD Case Rep. 2018 Oct 03;4(9):880-882. doi: 10.1016/j.jdcr.2018.08.008. eCollection 2018 Oct. PMID: 30306117; PMCID: PMC6172435.
Copy Download .nbib Format: NLM
[No title available]

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Lauinger J, Volc S, Ghoreschi K.
PMID: 32130777
J Dtsch Dermatol Ges. 2020 Mar;18(3):266-270. doi: 10.1111/ddg.14037_g.

No abstract available.

Cite
Lauinger J, Volc S, Ghoreschi K. Bullöse Hautveränderungen bei einem 65-jährigen Mann. . J Dtsch Dermatol Ges. 2020;18(3):266-270doi: 10.1111/ddg.14037_g.
Lauinger, J., Volc, S., & Ghoreschi, K. (2020). Bullöse Hautveränderungen bei einem 65-jährigen Mann. . Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 18(3), 266-270. https://doi.org/10.1111/ddg.14037_g
Lauinger, Julia, et al. "Bullöse Hautveränderungen bei einem 65-jährigen Mann." . Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG vol. 18,3 (2020): 266-270. doi: https://doi.org/10.1111/ddg.14037_g
Lauinger J, Volc S, Ghoreschi K. Bullöse Hautveränderungen bei einem 65-jährigen Mann. . J Dtsch Dermatol Ges. 2020 Mar;18(3):266-270. doi: 10.1111/ddg.14037_g. German. PMID: 32130777.
Copy Download .nbib Format: NLM
[No title available]

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Lintzeri DA, Constantinou A, Hillmann K, Ghoreschi K, Vogt A, Blume-Peytavi U.
PMID: 35040563
J Dtsch Dermatol Ges. 2022 Jan;20(1):59-93. doi: 10.1111/ddg.14689_g.

No abstract available.

Cite
Lintzeri DA, Constantinou A, Hillmann K, et al. Alopecia areata - Aktuelles Verständnis und Management. . J Dtsch Dermatol Ges. 2022;20(1):59-93doi: 10.1111/ddg.14689_g.
Lintzeri, D. A., Constantinou, A., Hillmann, K., Ghoreschi, K., Vogt, A., & Blume-Peytavi, U. (2022). Alopecia areata - Aktuelles Verständnis und Management. . Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 20(1), 59-93. https://doi.org/10.1111/ddg.14689_g
Lintzeri, Dimitra Aikaterini, et al. "Alopecia areata - Aktuelles Verständnis und Management." . Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG vol. 20,1 (2022): 59-93. doi: https://doi.org/10.1111/ddg.14689_g
Lintzeri DA, Constantinou A, Hillmann K, Ghoreschi K, Vogt A, Blume-Peytavi U. Alopecia areata - Aktuelles Verständnis und Management. . J Dtsch Dermatol Ges. 2022 Jan;20(1):59-93. doi: 10.1111/ddg.14689_g. German. PMID: 35040563.
Copy Download .nbib Format: NLM
The inflammation in cutaneous lichen planus is dominated by IFN-ϒ and IL-21-A basis for therapeutic JAK1 inhibition.

Experimental dermatology

Pietschke K, Holstein J, Meier K, Schäfer I, Müller-Hermelink E, Gonzalez-Menendez I, Quintanilla-Martinez L, Ghoreschi FC, Solimani F, Ghoreschi K.
PMID: 33113249
Exp Dermatol. 2021 Feb;30(2):262-270. doi: 10.1111/exd.14226. Epub 2020 Nov 12.

Cutaneous lichen planus (CLP) and psoriasis (PSO) are both common chronic inflammatory skin diseases for which development of new treatments requires the identification of key targets. While PSO is a typical Th17/IL-17-disorder, there is some evidence that Th1/IFN-ɣ dominate...

Cite
Pietschke K, Holstein J, Meier K, et al. The inflammation in cutaneous lichen planus is dominated by IFN-ϒ and IL-21-A basis for therapeutic JAK1 inhibition. Exp Dermatol. 2020;30(2):262-270doi: 10.1111/exd.14226.
Pietschke, K., Holstein, J., Meier, K., Schäfer, I., Müller-Hermelink, E., Gonzalez-Menendez, I., Quintanilla-Martinez, L., Ghoreschi, F. C., Solimani, F., & Ghoreschi, K. (2021). The inflammation in cutaneous lichen planus is dominated by IFN-ϒ and IL-21-A basis for therapeutic JAK1 inhibition. Experimental dermatology, 30(2), 262-270. https://doi.org/10.1111/exd.14226
Pietschke, Katharina, et al. "The inflammation in cutaneous lichen planus is dominated by IFN-ϒ and IL-21-A basis for therapeutic JAK1 inhibition." Experimental dermatology vol. 30,2 (2021): 262-270. doi: https://doi.org/10.1111/exd.14226
Pietschke K, Holstein J, Meier K, Schäfer I, Müller-Hermelink E, Gonzalez-Menendez I, Quintanilla-Martinez L, Ghoreschi FC, Solimani F, Ghoreschi K. The inflammation in cutaneous lichen planus is dominated by IFN-ϒ and IL-21-A basis for therapeutic JAK1 inhibition. Exp Dermatol. 2021 Feb;30(2):262-270. doi: 10.1111/exd.14226. Epub 2020 Nov 12. PMID: 33113249.
Copy Download .nbib Format: NLM
Arginase 1.

Experimental dermatology

Neri D, Carevic-Neri M, Brück J, Holstein J, Schäfer I, Solimani F, Handgretinger R, Hartl D, Ghoreschi K.
PMID: 33528891
Exp Dermatol. 2021 Jun;30(6):782-791. doi: 10.1111/exd.14298. Epub 2021 Feb 23.

Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of immature myeloid cells, which are characterized by their capability to suppress T-cell responses. While MDSCs have been traditionally associated with cancer diseases, their role as regulators of autoimmune diseases is...

Cite
Neri D, Carevic-Neri M, Brück J, et al. Arginase 1. Exp Dermatol. 2021;30(6):782-791doi: 10.1111/exd.14298.
Neri, D., Carevic-Neri, M., Brück, J., Holstein, J., Schäfer, I., Solimani, F., Handgretinger, R., Hartl, D., & Ghoreschi, K. (2021). Arginase 1. Experimental dermatology, 30(6), 782-791. https://doi.org/10.1111/exd.14298
Neri, Davide, et al. "Arginase 1." Experimental dermatology vol. 30,6 (2021): 782-791. doi: https://doi.org/10.1111/exd.14298
Neri D, Carevic-Neri M, Brück J, Holstein J, Schäfer I, Solimani F, Handgretinger R, Hartl D, Ghoreschi K. Arginase 1. Exp Dermatol. 2021 Jun;30(6):782-791. doi: 10.1111/exd.14298. Epub 2021 Feb 23. PMID: 33528891.
Copy Download .nbib Format: NLM
Years of life lost due to gastric cancer is increased after Bayesian correcting for misclassification in Iranian population.

Gastroenterology and hepatology from bed to bench

Hajizadeh N, Pourhoseingholi MA, Baghestani AR, Abadi A, Ghoreshi B.
PMID: 27895855
Gastroenterol Hepatol Bed Bench. 2016;9(4):295-300.

AIM: To estimate the change in years of life lost (YLL) due to gastric cancer mortality after correcting for misclassification in registering causes of death using the Bayesian method.BACKGROUND: For evaluating the health status of a country and determining...

Cite
Hajizadeh N, Pourhoseingholi MA, Baghestani AR, et al. Years of life lost due to gastric cancer is increased after Bayesian correcting for misclassification in Iranian population. Gastroenterol Hepatol Bed Bench. 2016;9(4):295-300
Hajizadeh, N., Pourhoseingholi, M. A., Baghestani, A. R., Abadi, A., & Ghoreshi, B. (2016). Years of life lost due to gastric cancer is increased after Bayesian correcting for misclassification in Iranian population. Gastroenterology and hepatology from bed to bench, 9(4), 295-300.
Hajizadeh, Nastaran, et al. "Years of life lost due to gastric cancer is increased after Bayesian correcting for misclassification in Iranian population." Gastroenterology and hepatology from bed to bench vol. 9,4 (2016): 295-300.
Hajizadeh N, Pourhoseingholi MA, Baghestani AR, Abadi A, Ghoreshi B. Years of life lost due to gastric cancer is increased after Bayesian correcting for misclassification in Iranian population. Gastroenterol Hepatol Bed Bench. 2016;9(4):295-300. PMID: 27895855; PMCID: PMC5118854.
Copy Download .nbib Format: NLM
Therapeutic evaluation of immunomodulators in reducing surgical wound infection.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Mahmud F, Roy R, Mohamed MF, Aboonabi A, Moric M, Ghoreishi K, Bayat M, Kuzel TM, Reiser J, Shafikhani SH.
PMID: 34907595
FASEB J. 2022 Jan;36(1):e22090. doi: 10.1096/fj.202101019R.

Despite many advances in infection control practices, including prophylactic antibiotics, surgical site infections (SSIs) remain a significant cause of morbidity, prolonged hospitalization, and death worldwide. Our innate immune system possesses a multitude of powerful antimicrobial strategies which make it...

Cite
Mahmud F, Roy R, Mohamed MF, et al. Therapeutic evaluation of immunomodulators in reducing surgical wound infection. FASEB J. 2022;36(1):e22090doi: 10.1096/fj.202101019R.
Mahmud, F., Roy, R., Mohamed, M. F., Aboonabi, A., Moric, M., Ghoreishi, K., Bayat, M., Kuzel, T. M., Reiser, J., & Shafikhani, S. H. (2022). Therapeutic evaluation of immunomodulators in reducing surgical wound infection. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 36(1), e22090. https://doi.org/10.1096/fj.202101019R
Mahmud, Foyez, et al. "Therapeutic evaluation of immunomodulators in reducing surgical wound infection." FASEB journal : official publication of the Federation of American Societies for Experimental Biology vol. 36,1 (2022): e22090. doi: https://doi.org/10.1096/fj.202101019R
Mahmud F, Roy R, Mohamed MF, Aboonabi A, Moric M, Ghoreishi K, Bayat M, Kuzel TM, Reiser J, Shafikhani SH. Therapeutic evaluation of immunomodulators in reducing surgical wound infection. FASEB J. 2022 Jan;36(1):e22090. doi: 10.1096/fj.202101019R. PMID: 34907595.
Copy Download .nbib Format: NLM
Arginase 1.

Experimental dermatology

Neri D, Carevic-Neri M, Brück J, Holstein J, Schäfer I, Solimani F, Handgretinger R, Hartl D, Ghoreschi K.
PMID: 33528891
Exp Dermatol. 2021 Jun;30(6):782-791. doi: 10.1111/exd.14298. Epub 2021 Feb 23.

Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of immature myeloid cells, which are characterized by their capability to suppress T-cell responses. While MDSCs have been traditionally associated with cancer diseases, their role as regulators of autoimmune diseases is...

Cite
Neri D, Carevic-Neri M, Brück J, et al. Arginase 1. Exp Dermatol. 2021;30(6):782-791doi: 10.1111/exd.14298.
Neri, D., Carevic-Neri, M., Brück, J., Holstein, J., Schäfer, I., Solimani, F., Handgretinger, R., Hartl, D., & Ghoreschi, K. (2021). Arginase 1. Experimental dermatology, 30(6), 782-791. https://doi.org/10.1111/exd.14298
Neri, Davide, et al. "Arginase 1." Experimental dermatology vol. 30,6 (2021): 782-791. doi: https://doi.org/10.1111/exd.14298
Neri D, Carevic-Neri M, Brück J, Holstein J, Schäfer I, Solimani F, Handgretinger R, Hartl D, Ghoreschi K. Arginase 1. Exp Dermatol. 2021 Jun;30(6):782-791. doi: 10.1111/exd.14298. Epub 2021 Feb 23. PMID: 33528891.
Copy Download .nbib Format: NLM
[No title available]

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Peters N, Schubert M, Bauer J, Ghoreschi FC, Moehrle M.
PMID: 31765084
J Dtsch Dermatol Ges. 2019 Nov;17(11):1131-1140. doi: 10.1111/ddg.13937_g.

No abstract available.

Cite
Peters N, Schubert M, Bauer J, et al. Rapid Lump Examination (RLE) - eine schnelle Methode in der mikroskopisch kontrollierten Chirurgie von Basalzellkarzinomen. . J Dtsch Dermatol Ges. 2019;17(11):1131-1140doi: 10.1111/ddg.13937_g.
Peters, N., Schubert, M., Bauer, J., Ghoreschi, F. C., & Moehrle, M. (2019). Rapid Lump Examination (RLE) - eine schnelle Methode in der mikroskopisch kontrollierten Chirurgie von Basalzellkarzinomen. . Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 17(11), 1131-1140. https://doi.org/10.1111/ddg.13937_g
Peters, Nina, et al. "Rapid Lump Examination (RLE) - eine schnelle Methode in der mikroskopisch kontrollierten Chirurgie von Basalzellkarzinomen." . Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG vol. 17,11 (2019): 1131-1140. doi: https://doi.org/10.1111/ddg.13937_g
Peters N, Schubert M, Bauer J, Ghoreschi FC, Moehrle M. Rapid Lump Examination (RLE) - eine schnelle Methode in der mikroskopisch kontrollierten Chirurgie von Basalzellkarzinomen. . J Dtsch Dermatol Ges. 2019 Nov;17(11):1131-1140. doi: 10.1111/ddg.13937_g. German. PMID: 31765084.
Copy Download .nbib Format: NLM
Interleukin 4 as a potential drug candidate for psoriasis.

Expert opinion on drug discovery

Weigert C, Röcken M, Ghoreschi K.
PMID: 23480267
Expert Opin Drug Discov. 2008 Mar;3(3):357-68. doi: 10.1517/17460441.3.3.357.

BACKGROUND: Interleukin 4 (IL-4) is the central cytokine driving the differentiation of naive CD4(+) T helper (TH) cells into anti-inflammatory IL-4-producing TH2 cells. In contrast, IL-12/IL-23 promotes the development of TH1/TH17 immune responses that induce organ-specific autoimmune diseases such...

Cite
Weigert C, Röcken M, Ghoreschi K. Interleukin 4 as a potential drug candidate for psoriasis. Expert Opin Drug Discov. 2008;3(3):357-68doi: 10.1517/17460441.3.3.357.
Weigert, C., Röcken, M., & Ghoreschi, K. (2008). Interleukin 4 as a potential drug candidate for psoriasis. Expert opinion on drug discovery, 3(3), 357-68. https://doi.org/10.1517/17460441.3.3.357
Weigert, Christina, et al. "Interleukin 4 as a potential drug candidate for psoriasis." Expert opinion on drug discovery vol. 3,3 (2008): 357-68. doi: https://doi.org/10.1517/17460441.3.3.357
Weigert C, Röcken M, Ghoreschi K. Interleukin 4 as a potential drug candidate for psoriasis. Expert Opin Drug Discov. 2008 Mar;3(3):357-68. doi: 10.1517/17460441.3.3.357. PMID: 23480267.
Copy Download .nbib Format: NLM
Preventive Effect of Hydroalcoholic Extract of .

International journal of preventive medicine

Rahimi M, Ghoreshi M, Emami B, Shafei MN, Hosseini M, Khajavirad A.
PMID: 30450175
Int J Prev Med. 2018 Oct 12;9:92. doi: 10.4103/ijpvm.IJPVM_312_17. eCollection 2018.

METHODS: After anesthesia, femoral artery and vein of rats were cannulated for recording cardiovascular responses and drug injection, respectively. Systolic blood pressure (SBP), mean arterial blood pressure (MAP), and heart rate (HR) were recorded continuously by power lab software....

Cite
Rahimi M, Ghoreshi M, Emami B, et al. Preventive Effect of Hydroalcoholic Extract of . Int J Prev Med. 2018;9:92doi: 10.4103/ijpvm.IJPVM_312_17.
Rahimi, M., Ghoreshi, M., Emami, B., Shafei, M. N., Hosseini, M., & Khajavirad, A. (2018). Preventive Effect of Hydroalcoholic Extract of . International journal of preventive medicine, 992. https://doi.org/10.4103/ijpvm.IJPVM_312_17
Rahimi, Maryam, et al. "Preventive Effect of Hydroalcoholic Extract of ." International journal of preventive medicine vol. 9 (2018): 92. doi: https://doi.org/10.4103/ijpvm.IJPVM_312_17
Rahimi M, Ghoreshi M, Emami B, Shafei MN, Hosseini M, Khajavirad A. Preventive Effect of Hydroalcoholic Extract of . Int J Prev Med. 2018 Oct 12;9:92. doi: 10.4103/ijpvm.IJPVM_312_17. eCollection 2018. PMID: 30450175; PMCID: PMC6202776.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 37 entries